Andrew H. Ko

Career Trajectory

Research Cluster Map

Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.

• Abstract 2131: Hyperpolarized carbon-13 MRI for early treatment response assessment in pancreatic ductal adenocarcinoma patients.

  Cancer Research · 2026-04-03

• Efficacy of the ATR Inhibitor Ceralasertib in Patients with ARID1A-Deficient Gynecologic and Other Solid Tumor Malignancies

  Clinical Cancer Research · 2026-02-13

• Effect of Target Selection on Mood, Anxiety, Pain, and Medications after Deep Brain Stimulation in Parkinson’s DiseasePreprint

  SSRN Electronic Journal · 2026-01-01

• Effect of Target Selection on Mood, Anxiety, Pain, and Medications after Deep Brain Stimulation in Parkinson’s DiseasePreprint

  SSRN Electronic Journal · 2026-01-01

• Avutometinib/defactinib and gemcitabine/nab-paclitaxel combination in first-line metastatic pancreatic ductal adenocarcinoma: Updated safety and efficacy of a phase 1b/2 study (RAMP 205).

  Journal of Clinical Oncology · 2025-05-28 · 2 citations

• Early-Phase Trials in <i>Journal of Clinical Oncology</i>

  Journal of Clinical Oncology · 2025-05-22 · 1 citations

• Consensus guidelines for infection reduction in deep brain stimulation surgery: A literature review and modified Delphi study

  Deep Brain Stimulation · 2025-04-07

• Safety and preliminary efficacy of ivaltinostat, an HDAC inhibitor, plus capecitabine in patients with pretreated metastatic pancreatic adenocarcinoma (mPDAC): Results of a phase Ib study.

  Journal of Clinical Oncology · 2025-01-27

• Pamrevlumab plus nab-paclitaxel/gemcitabine (Pam + GA) as first- and second-line therapy in metastatic pancreatic cancer (mPDAC): Results from Precision Promise (PrP) Bayesian platform trial.

  Journal of Clinical Oncology · 2025-01-27 · 2 citations

• Long-term safety of lentiviral or gammaretroviral gene-modified T cell therapies

  Nature Medicine · 2025-01-20 · 71 citations

• Consensus guidance for prevention and management of nausea and vomiting in patients treated with zolbetuximab + chemotherapy: a RAND/UCLA modified Delphi panel study

  ESMO Gastrointestinal Oncology · 2025-01-18 · 10 citations

• Shedding Sunshine on Gender Inequities in Industry Compensation to Physicians: a Centers for Medicare and Medicaid Services Open Payment Analysis.

  PubMed · 2025-01-01

• 2025

  Journal of Surgical Orthopaedic Advances · 2025-01-01

• Investigational Use of Real‐World Data as a Hybrid Control in Pancreatic Ductal Adenocarcinoma From the Randomized Phase Ib/<scp>II MORPHEUS</scp> Trial

  Clinical Pharmacology & Therapeutics · 2024-12-20 · 6 citations

• 381P Treatment rechallenge after grade 1 trastuzumab-deruxtecan related interstitial lung disease: A real-world experience

  Annals of Oncology · 2024-09-01 · 4 citations

• ASO Visual Abstract: Long-Duration Neoadjuvant Therapy with FOLFIRINOX Yields Favorable Outcomes for Patients Who Undergo Surgery for Pancreatic Cancer

  Annals of Surgical Oncology · 2024-07-27

• Circulating KRAS G12D but not G12V is associated with survival in metastatic pancreatic ductal adenocarcinoma

  Nature Communications · 2024-07-09 · 13 citations